These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 38703766)

  • 1. Targeting low levels of MIF expression as a potential therapeutic strategy for ALS.
    Alfahel L; Gschwendtberger T; Kozareva V; Dumas L; Gibbs R; Kertser A; Baruch K; Zaccai S; Kahn J; Thau-Habermann N; Eggenschwiler R; Sterneckert J; Hermann A; Sundararaman N; Vaibhav V; Van Eyk JE; Rafuse VF; Fraenkel E; Cantz T; Petri S; Israelson A
    Cell Rep Med; 2024 May; 5(5):101546. PubMed ID: 38703766
    [TBL] [Abstract][Full Text] [Related]  

  • 2. AAV2/9-mediated overexpression of MIF inhibits SOD1 misfolding, delays disease onset, and extends survival in mouse models of ALS.
    Leyton-Jaimes MF; Kahn J; Israelson A
    Proc Natl Acad Sci U S A; 2019 Jul; 116(29):14755-14760. PubMed ID: 31262807
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endogenous macrophage migration inhibitory factor reduces the accumulation and toxicity of misfolded SOD1 in a mouse model of ALS.
    Leyton-Jaimes MF; Benaim C; Abu-Hamad S; Kahn J; Guetta A; Bucala R; Israelson A
    Proc Natl Acad Sci U S A; 2016 Sep; 113(36):10198-203. PubMed ID: 27551074
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MIF homolog d-dopachrome tautomerase (D-DT/MIF-2) does not inhibit accumulation and toxicity of misfolded SOD1.
    Alaskarov A; Barel S; Bakavayev S; Kahn J; Israelson A
    Sci Rep; 2022 Jun; 12(1):9570. PubMed ID: 35688953
    [TBL] [Abstract][Full Text] [Related]  

  • 5. AAV-NRIP gene therapy ameliorates motor neuron degeneration and muscle atrophy in ALS model mice.
    Chen HH; Yeo HT; Huang YH; Tsai LK; Lai HJ; Tsao YP; Chen SL
    Skelet Muscle; 2024 Jul; 14(1):17. PubMed ID: 39044305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coactivation of GSK3β and IGF-1 Attenuates Amyotrophic Lateral Sclerosis Nerve Fiber Cytopathies in SOD1 Mutant Patient-Derived Motor Neurons.
    Ting HC; Yang HI; Harn HJ; Chiu IM; Su HL; Li X; Chen MF; Ho TJ; Liu CA; Tsai YJ; Chiou TW; Lin SZ; Chang CY
    Cells; 2021 Oct; 10(10):. PubMed ID: 34685754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MIF inhibits the formation and toxicity of misfolded SOD1 amyloid aggregates: implications for familial ALS.
    Shvil N; Banerjee V; Zoltsman G; Shani T; Kahn J; Abu-Hamad S; Papo N; Engel S; Bernhagen J; Israelson A
    Cell Death Dis; 2018 Jan; 9(2):107. PubMed ID: 29371591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Macrophage migration inhibitory factor as a chaperone inhibiting accumulation of misfolded SOD1.
    Israelson A; Ditsworth D; Sun S; Song S; Liang J; Hruska-Plochan M; McAlonis-Downes M; Abu-Hamad S; Zoltsman G; Shani T; Maldonado M; Bui A; Navarro M; Zhou H; Marsala M; Kaspar BK; Da Cruz S; Cleveland DW
    Neuron; 2015 Apr; 86(1):218-32. PubMed ID: 25801706
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pericytes Extend Survival of ALS SOD1 Mice and Induce the Expression of Antioxidant Enzymes in the Murine Model and in IPSCs Derived Neuronal Cells from an ALS Patient.
    Coatti GC; Frangini M; Valadares MC; Gomes JP; Lima NO; Cavaçana N; Assoni AF; Pelatti MV; Birbrair A; de Lima ACP; Singer JM; Rocha FMM; Da Silva GL; Mantovani MS; Macedo-Souza LI; Ferrari MFR; Zatz M
    Stem Cell Rev Rep; 2017 Oct; 13(5):686-698. PubMed ID: 28710685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic AAV9-mediated suppression of mutant SOD1 slows disease progression and extends survival in models of inherited ALS.
    Foust KD; Salazar DL; Likhite S; Ferraiuolo L; Ditsworth D; Ilieva H; Meyer K; Schmelzer L; Braun L; Cleveland DW; Kaspar BK
    Mol Ther; 2013 Dec; 21(12):2148-59. PubMed ID: 24008656
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induced pluripotent stem cell-derived motor neurons from amyotrophic lateral sclerosis (ALS) patients carrying different superoxide dismutase 1 mutations recapitulate pathological features of ALS.
    Liu WC; Liu N; Wang Y; Huang C; Li YF; Wang H; Li XG; Deng M
    Chin Med J (Engl); 2021 Oct; 134(20):2457-2464. PubMed ID: 34669638
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting of monomer/misfolded SOD1 as a therapeutic strategy for amyotrophic lateral sclerosis.
    Liu HN; Tjostheim S; Dasilva K; Taylor D; Zhao B; Rakhit R; Brown M; Chakrabartty A; McLaurin J; Robertson J
    J Neurosci; 2012 Jun; 32(26):8791-9. PubMed ID: 22745481
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An integrative miRNA-mRNA expression analysis identifies miRNA signatures associated with SOD1 and TARDBP patient-derived motor neurons.
    Dash BP; Freischmidt A; Weishaupt JH; Hermann A
    Hum Mol Genet; 2024 Jul; 33(15):1300-1314. PubMed ID: 38676626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Wild-type Cu/Zn-superoxide dismutase is misfolded in cerebrospinal fluid of sporadic amyotrophic lateral sclerosis.
    Tokuda E; Takei YI; Ohara S; Fujiwara N; Hozumi I; Furukawa Y
    Mol Neurodegener; 2019 Nov; 14(1):42. PubMed ID: 31744522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Misfolded SOD1 is not a primary component of sporadic ALS.
    Da Cruz S; Bui A; Saberi S; Lee SK; Stauffer J; McAlonis-Downes M; Schulte D; Pizzo DP; Parone PA; Cleveland DW; Ravits J
    Acta Neuropathol; 2017 Jul; 134(1):97-111. PubMed ID: 28247063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic Correction of SOD1 Mutant iPSCs Reveals ERK and JNK Activated AP1 as a Driver of Neurodegeneration in Amyotrophic Lateral Sclerosis.
    Bhinge A; Namboori SC; Zhang X; VanDongen AMJ; Stanton LW
    Stem Cell Reports; 2017 Apr; 8(4):856-869. PubMed ID: 28366453
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aberrant localization of FUS and TDP43 is associated with misfolding of SOD1 in amyotrophic lateral sclerosis.
    Pokrishevsky E; Grad LI; Yousefi M; Wang J; Mackenzie IR; Cashman NR
    PLoS One; 2012; 7(4):e35050. PubMed ID: 22493728
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased surface P2X4 receptors by mutant SOD1 proteins contribute to ALS pathogenesis in SOD1-G93A mice.
    Bertin E; Martinez A; Fayoux A; Carvalho K; Carracedo S; Fernagut PO; Koch-Nolte F; Blum D; Bertrand SS; Boué-Grabot E
    Cell Mol Life Sci; 2022 Jul; 79(8):431. PubMed ID: 35852606
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional links between SQSTM1 and ALS2 in the pathogenesis of ALS: cumulative impact on the protection against mutant SOD1-mediated motor dysfunction in mice.
    Hadano S; Mitsui S; Pan L; Otomo A; Kubo M; Sato K; Ono S; Onodera W; Abe K; Chen X; Koike M; Uchiyama Y; Aoki M; Warabi E; Yamamoto M; Ishii T; Yanagawa T; Shang HF; Yoshii F
    Hum Mol Genet; 2016 Aug; 25(15):3321-3340. PubMed ID: 27439389
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The inhibitory effects of MIF on accumulation of canine degenerative myelopathy-associated mutant SOD1 aggregation.
    Nomura S; Kobatake Y; Takashima S; Kamishina H; Urushitani M; Nishii N
    Res Vet Sci; 2022 Oct; 147():7-11. PubMed ID: 35364344
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.